How effective are alprostadil and hydrocortisone on reperfusion injury in kidney after distant organ ischemia?

Journal of Research in Medical Sciences

Volumn 18, Issue 9, 2013, Pages 755-758

  Ebrahimi, Ali ^a   Salimi, Fereshteh ^b   Safaei, Mansour ^b   Melali, Hamid ^b   Jazi, Amir Hosein Davarpanah ^a,b   Nematbakhsh, Mehdi ^b   Mokhtari, Mojgan ^b   Rasooli, Hamidreza ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alprostadil; Hydrocortisone; Ischemia reperfusion injury; Oxidative stress

Indexed keywords

GLUTATHIONE; HYDROCORTISONE; MALONALDEHYDE; PROSTAGLANDIN E1; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; ISCHEMIA; LAPAROTOMY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY;

EID: 84886796317     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Crinnion JN, Homer-Vanniasinkam S, Gough MJ. Skeletal muscle reperfusion injury: Pathophysiology and clinical considerations. Cardiovasc Surg 1993;1:317-24.
2. Adams JG Jr, Dhar A, Shukla SD, Silver D. Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injury. J Vasc Surg 1995;21:742-8.
3. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: A novel protective method from ischemia reperfusion injury--a review. J Surg Res 2008;150:304-30.
4. Carden DL, Granger DN. Pathophysiology of ischaemiareperfusion injury. J Pathol 2000;190:255-66.
5. Qiao Z, Ma J, Liu H. Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemiareperfusion injury. Molecules 2011;16:10002-12.
6. Enc Y, Karaca P, Ayoglu U, Camur G, Kurc E, Cicek S. The acute cardioprotective effect of glucocorticoid in myocardial ischemiareperfusion injury occurring during cardiopulmonary bypass. Heart Vessels 2006;21:152-6.
7. Chimalakonda AP, Mehvar R. Effects of methylprednisolone and its liver-targeted dextran prodrug on ischemia-reperfusion injury in a rat liver transplantation model. Pharm Res 2007;24:2231-8.
8. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011;31:986-1000.
9. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990;186:421-31.
10. Naziroglu M, Dilsiz N, Cay M. Protective role of intraperitoneally administered vitamins C and E and selenium on the levels of lipid peroxidation in the lens of rats made diabetic with streptozotocin. Biol Trace Elem Res 1999;70:223-32.
11. Iwata K, Shimazu M, Wakabayashi G, Ohshima A, Yoshida M, Kitajima M. Intraportal perfusion of prostaglandin E1 attenuates hepatic postischaemic microcirculatory impairments in rats. J Gastroenterol Hepatol 1999;14:634-41.
12. Milcan A, Arslan E, Bagdatoglu OT, Bagdatoglu C, Polat G, Kanik A, et al. The effect of alprostadil on ischemia-reperfusion injury of peripheral nerve in rats. Pharmacol Res 2004;49:67-72.
13. Pararajasingam R, Weight SC, Bell PR, Nicholson ML, Sayers RD. Prevention of renal impairment following aortic cross-clamping by manipulation of the endogenous renal nitric oxide response. Eur J Vasc Endovasc Surg 2000;19:396-9.
14. Seok YM, Kim J, Choi KC, Yoon CH, Boo YC, Park Y, et al. Wenpi- tang-Hab-Wu-ling-san attenuates kidney ischemia/reperfusion injury in mice. A role for antioxidant enzymes and heat-shock proteins. J Ethnopharmacol 2007;112:333-40.
15. Slivka AP, Murphy EJ. High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp Neurol 2001;167:166-72.
16. Parra C, Salas P, Dominguez J. Effects of immunosuppressive drugs on rat renal ischemia reperfusion injury. Transplant Proc 2010;42:245-7.
17. Sketch MH Jr, Whelton A, Schollmayer E, Koch JA, Bernink PJ, Woltering F, et al. Prostaglandin E1 Study Group. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: A randomized, double-blind, placebo-controlled study. Am J Ther 2001;8:155-62.
18. de Perrot M, Fischer S, Liu M, Jin R, Bai XH, Waddell TK, et al. Prostaglandin E1 protects lung transplants from ischemiareperfusion injury: A shift from pro- to anti-inflammatory cytokines. Transplantation 2001;72:1505-12.
19. Huk I, Brovkovych V, Nanobashvili J, Neumayer C, Polterauer P, Prager M, et al. Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock 2000;14:234-42.
20. Mahmoud IM, Hussein Ael-A, Sarhan ME, Awad AA, El Desoky I. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury. Nephron Physiol 2007;105:p 57-65.